The Skin: A superior route of drug delivery for many drugs

Dyve’s novel transdermal delivery technology delivers existing drugs through the skin, improving safety, efficacy, and ease of use over existing routes of delivery.

Dyve’s technology fluidizes the stratum corneum lipid matrix and modulates cellular junctions to transiently create a paracellular drug delivery pathway that leverages the body’s largest organ – the skin – as a delivery portal.

Broad Applicability

Data set in pre-clinical and human testing across a range of molecules demonstrates ability to overcome historically challenging chemical characteristics (size, solubility, lipophilicity, etc.).

PK + Efficacy Validation

In a pay-load and platform specific way, Dyve has shown robust pharmacokinetic and efficacy benefits versus existing routes of delivery – fast, efficient, and convenient dosing that non-invasively bypasses GI challenges for local or systemic delivery.